Catalog |
name |
Description |
price |
R-C-3336 |
DSPE-PEG350-GCRGDCS |
Peptides as receptor targeted anti-tumor carrier are more and more used to improve the effect of chemotherapy drugs.It has been proved by experiments that peptides can improve the anti-tumor effect by enhancing the targeting specificity of drugs,enhancing the targeted absorption of drugs,and improving the original insoluble properties of some small molecular drugs.Peptide carrier targeting technology is known as a new generation of targeted drug development technology. |
price> |
R-C-3337 |
DSPE-PEG550-GCRGDCS |
Peptides as receptor targeted anti-tumor carrier are more and more used to improve the effect of chemotherapy drugs.It has been proved by experiments that peptides can improve the anti-tumor effect by enhancing the targeting specificity of drugs,enhancing the targeted absorption of drugs,and improving the original insoluble properties of some small molecular drugs.Peptide carrier targeting technology is known as a new generation of targeted drug development technology. |
price> |
R-C-3338 |
DSPE-PEG750-GCRGDCS |
Peptides as receptor targeted anti-tumor carrier are more and more used to improve the effect of chemotherapy drugs.It has been proved by experiments that peptides can improve the anti-tumor effect by enhancing the targeting specificity of drugs,enhancing the targeted absorption of drugs,and improving the original insoluble properties of some small molecular drugs.Peptide carrier targeting technology is known as a new generation of targeted drug development technology. |
price> |
R-C-3339 |
DSPE peg350 affinity peptide p1c |
Liposomes can passively enter tumor tissue through enhanced retention and retention effect (EPR).Compared with radiotherapy and chemotherapy alone, liposomes have certain clinical treatment advantages.However,due to the rapid blood flow,liposomes can not stay in the tumor site for a long time after entering the body through intravenous injection.However,the targeted liposome prepared by connecting peptide on the surface of liposome can reach the target site immediately after intravenous injection and stay in the tumor site for a long time.The drug released from the liposome can improve the therapeutic effect of tumor. |
price> |
R-C-3340 |
DSPE peg550 affinity peptide p1c |
Liposomes can passively enter tumor tissue through enhanced retention and retention effect (EPR).Compared with radiotherapy and chemotherapy alone, liposomes have certain clinical treatment advantages.However,due to the rapid blood flow,liposomes can not stay in the tumor site for a long time after entering the body through intravenous injection.However,the targeted liposome prepared by connecting peptide on the surface of liposome can reach the target site immediately after intravenous injection and stay in the tumor site for a long time.The drug released from the liposome can improve the therapeutic effect of tumor. |
price> |
R-C-3341 |
DSPE peg750 affinity peptide p1c |
Liposomes can passively enter tumor tissue through enhanced retention and retention effect (EPR).Compared with radiotherapy and chemotherapy alone, liposomes have certain clinical treatment advantages.However,due to the rapid blood flow,liposomes can not stay in the tumor site for a long time after entering the body through intravenous injection.However,the targeted liposome prepared by connecting peptide on the surface of liposome can reach the target site immediately after intravenous injection and stay in the tumor site for a long time.The drug released from the liposome can improve the therapeutic effect of tumor. |
price> |
R-C-3342 |
DSPE-PEG350-preS1 |
The pres/s coding region of hepatitis B virus encodes two polypeptides (PreS1 and preS2),which are larger than the virus surface antigen (s) protein,but are not abundant.Different from preS2 and S proteins,PreS1 protein preferentially located on circulating virus particles,but could not be effectively secreted in cultured mammalian cells. |
price> |
R-C-3343 |
DSPE-PEG550-preS1 |
The pres/s coding region of hepatitis B virus encodes two polypeptides (PreS1 and preS2),which are larger than the virus surface antigen (s) protein,but are not abundant.Different from preS2 and S proteins,PreS1 protein preferentially located on circulating virus particles,but could not be effectively secreted in cultured mammalian cells. |
price> |
R-C-3344 |
DSPE-PEG750-preS1 |
The pres/s coding region of hepatitis B virus encodes two polypeptides (PreS1 and preS2),which are larger than the virus surface antigen (s) protein,but are not abundant.Different from preS2 and S proteins,PreS1 protein preferentially located on circulating virus particles,but could not be effectively secreted in cultured mammalian cells. |
price> |
R-C-3345 |
DSPE-PEG350-HBVpreS1(2-21Aa) |
Using HBVPreS1/2-21myr as target medium,long-acting circulating liposome (LCL) as drug carrier and fluorescein sodium (FS) as fluorescence mode to evaluate drugs,a novel drug delivery system targeting NTCP receptor was prepared by ethanol injection.HBVPreS1/2-21myr-peg2000-dspe was used as the raw material of liposome synthesis,mixed with soybean phospholipid,cholesterol and other liposome formula components,heated and prepared liposomes. |
price> |